Whether you are running an early Phase, a complete Phase 3 program or a bioequivalence clinical endpoint study, Symbio staff has specialized expertise, particularly with topical products.
The range of trial experience covers dermatology, anti-infectives and wound healing, internal medicine, ophthalmology, and women’s health.